Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-03-10
著者
-
Matsuhisa Akira
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
KINOYAMA Isao
Institute for Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.,
-
Mori Masamichi
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Kinoyama Isao
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Sasamata Masao
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Amino Nobuaki
Institute For Drug Discovery Research Astellas Pharma Inc.
-
NAKAHARA Takahito
Institute for Drug Discovery Research, Astellas Pharma, Inc.
-
KITA Aya
Institute for Drug Discovery Research, Astellas Pharma, Inc.
-
YAMANAKA Kentaro
Institute for Drug Discovery Research, Astellas Pharma, Inc.
-
TAKEUCHI Masahiro
Institute for Drug Discovery Research, Astellas Pharma, Inc.
-
TOMINAGA Fumiko
Institute for Drug Discovery Research, Astellas Pharma, Inc.
-
KUDOU Masafumi
Institute for Drug Discovery Research, Astellas Pharma, Inc.
-
Kita Aya
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Tominaga Fumiko
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Yamanaka Kentaro
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Matsuhisa Akira
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Kudou Masafumi
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Nakahara Takahito
Institute For Drug Discovery Research Astellas Pharma Inc.
-
Takeuchi Masahiro
Institute For Drug Discovery Research Astellas Pharma Inc.
関連論文
- 2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel Orally Active Antagonists of Platelet-Activating Factor (PAF)
- Preparation of Highly Potent and Selective Non-Peptide Antagonists of the Arginine Vasopressin V_ Receptor by Introduction of a 2-Ethyl-1H-1-imidazolyl Group
- Novel Potassium Channel Activators : Synthesis and Structure-Activity Relationship Studies of 3,4-Dihydro-2H-1,4-benzoxazine Derivatives
- Novel Potassium Chennel Activators. II. Synthesis and Pharmacological Evaluation of 3,4-Dihydro-2H-1,4-benzoxazine Derivatives : Modificaiton of the Aromatic Part
- Synthesis of Novel Succinamide Derivatives Having the 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M_2 Muscarinic Receptor Antagonists. I
- N-Arylpiperazine-1-carboxamide Derivatives : a Novel Series of Orally Active Nonsteroidal Androgen Receptor Antagonists
- Synthesis and Pharmacological Evaluation of Novel Arylpiperazine Derivatives as Nonsteroidal Androgen Receptor Antagonists
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 4'-(1,4,5,6-Tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanilide Derivatives and 4'-(5,6-Dihydro-4H-thiazolo[5,4-d][1]ben
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 2-Phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl)benzanilide Derivatives
- Synthesis and Biological Evaluation of 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent and Selective M_2 Muscarinic Receptor Antagonists
- Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M_2 Muscarinic Receptor Antagonists. II
- Stereoselective Synthesis of Methyl (Z)-(4,4-Difluoro-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylidene) acetate Using a Dianion Horner-Wadsworth-Emmons Reagent
- Preparation of Non-peptide, Highly Potent and Selective Antagonists of Arginine Vasopressin V_ Receptor by Introduction of Alkoxy Groups
- Highly Potent and Orally Active Non-Peptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 4'-[(4,4-Difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-yl)carbonyl]-2-phenylbenzani
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 2-Phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzanilide Derivatives
- Nonpeptide Arginine Vasopressin Antagonists for Both V_ and V_2 Receptors : Synthesis and Pharmacological Properties of 4'-[5-(Substituted Methylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl]benzanilide and 4'-[5-(Substituted Methyl)-2,3-dihy
- Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models